Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CVRx Inc CVRX

CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS... see more

Recent & Breaking News (NDAQ:CVRX)

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2 days ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire November 20, 2024

CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025

GlobeNewswire November 4, 2024

CVRx Reports Third Quarter 2024 Financial and Operating Results

GlobeNewswire October 29, 2024

CVRx announces new CPT® Category I codes for Barostim

GlobeNewswire October 18, 2024

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

GlobeNewswire October 15, 2024

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

GlobeNewswire September 12, 2024

CVRx Announces Appointment of Two New Board Members

GlobeNewswire September 3, 2024

CVRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Clients to Contact the Firm!

Accesswire August 21, 2024

CVRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Shareholders to Contact the Firm Today!

Accesswire August 20, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

Accesswire August 19, 2024

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

Accesswire August 19, 2024

CVRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Shareholders to Contact the Firm Today!

Accesswire August 19, 2024

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

Accesswire August 18, 2024

CVRX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Investors to Contact the Firm Today!

Accesswire August 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

PR Newswire August 17, 2024

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

Accesswire August 17, 2024

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

Accesswire August 16, 2024

CVRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Investors to Contact the Firm Today!

Accesswire August 16, 2024

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

Accesswire August 15, 2024